NeoVirTech

NeoVirTech

Recherche en biotechnologie

Virus and viral vector imaging in living cells applied to antiviral discovery and disinfection processes

À propos

NeoVirTech (NVT) is one of the leading virus imaging and antiviral discovery company in Europe. NVT has developed a breakthrough technology to directly visualize and quantify in real time virus/viral vector infection and replication in living cells, from high resolution to high content imaging. NVT possesses the exclusive worldwide license for the ANCHORTM technology that allows fast and efficient screening campaign. Our next generation technology can be applied in antiviral screening, gene delivery and oncolytic virotherapies. The beauty and quality of the data we generate are also a tremendous asset for communication and marketing. Our customers include academics centers, biotechnology companies and large pharmaceutical companies. Our offer is specifically designed for the anti-infectious, gene therapies, vaccines and oncolytic virotherapies market in human and animal health.

Secteur
Recherche en biotechnologie
Taille de l’entreprise
2-10 employés
Siège social
Toulouse
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2014
Domaines
Virology, High content screening, Custom design, fluorescence microscopy, Anti-Viral compounds, oncolytic virus, gene therapy, vaccine, imaging, biotech, high content imaging et drug screening

Lieux

Employés chez NeoVirTech

Nouvelles

Pages similaires

Parcourir les offres d’emploi